EXCITING PRESS

3 COVID Stocks That Might Double Soon

3 COVID Stocks That Might Double Soon

Motley Fool author, Patrick Bafuma, thinks InMode (NASDAQ: INMD) will close out 2021 with a bang. As the world slowly returns to normal and consumers seek treatments that they had delayed due to COVID-19, the aesthetics market is sure to heat up and is expected to grow, so there is plenty of room to run for InMode. “InMode (sic) demand is strong. Over one-third of the new patients coming in have never had any aesthetics procedure done before, “says InMode chief medical officer Dr. Spero Theodorou, “Waiting lists are about a month out.” With many of us either in the house or masked up since March 2020, Bafuma expects continued growth for InMode.

Read the article here.

 Seeking Alpha Logo

InMode: Taking Notes From Align Technologies

A new article in Seeking Alpha, by featured contributor Eric Groovenhoff, notes that “InMode has consistently executed its business flawlessly with exceptional margins,” under the guidance of its dedicated management with a long-term outlook. In conversation with Moshe Mizrahy, co-founder and CEO, he talked about how the technology operates today, and the direction the company can go over the next several years, “positioning it as a bullish stock, even at its current premium price.”

Read the article here.

InMode: Become More Beautiful Without Surgery

InMode: Become More Beautiful Without Surgery

InMode’s treatments render the human body more beautiful, gaining popularity as a minimally invasive alternative to surgery. This feature in Seeking Alpha reviews InMode’s innovative products, competitive landscape and financials.
Read the article here.

Are Investors Undervaluing InMode (NASDAQ:INMD) By 21%?

Are Investors Undervaluing InMode (NASDAQ:INMD) By 21%?

How far off is InMode Ltd. (NASDAQ: INMD) from its intrinsic value? As reported by Yahoo! Finance, Simply Wall St. used the most recent financial data to take a look at whether InMode stock is fairly priced by taking the forecast future cash flows of the company and discounting them back to today’s value. Compared to the current share price of US$91.7, the company appears a touch undervalued at a 21% discount to where the stock price trades currently.

Read the article here.

GOOGL Stock, Nvidia and InMode Lead Latest List Of New Buys By The Best Mutual Funds

GOOGL Stock, Nvidia and InMode Lead Latest List Of New Buys By The Best Mutual Funds

When you see the gains made by stocks like Alphabet (GOOGL), Nvidia (NVDA), Applied Materials (AMAT), Goldman Sachs (GS) and Charles Schwab (SCHW), it’s not hard to guess where the best mutual funds have been investing their money. In the IPO and medical sector, InMode (INMD), which went public in 2019, made the cut on top manager’s buy lists.

Read the article here.

How can we help?

Please select a topic below related to your inquiry.

Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us